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Early detection of Pseudomonas aeruginosa in children with cystic fibrosis is hampered by the need to process a sub-optimal specimen type,
namely cough swabs, which are known to have a lower positive yield than sputa or more invasive samples. This delay in the detection of low
levels of P. aeruginosa could potentially result in the loss of an opportunity to initiate early aggressive antibiotic therapy and result in chronic
colonisation, with a poorer overall prognosis. Quantitative real-time PCR (qPCR) offers an opportunity to increase the detection rate of
P. aeruginosa compared to traditional culture techniques. This study examined 500 cough swabs and 42 sputum samples from paediatric patients
and showed that detection of P. aeruginosa could be increased in both sample types by 100% and 45% respectively. Overall the sensitivity was
100% and specificity of 58% when compared to culture as a gold standard. These results although initially promising require careful consideration
both from a treatment and infection control standpoint as the significance of detection of very low levels of P. aeruginosa is unclear.
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Cystic fibrosis (CF) is an incurable, genetically inherited
disease that affects around 1 in 3000 individuals born in the UK.
The condition causes changes in the ion transport mechanisms
and although the disease affects several body systems it is
respiratory decline that proves ultimately fatal [1]
Over the past 30 years the prognosis for patients has improved
year on yearmainly due to aggressive clinical interventions aimed
atmaintaining good lung function and patientsmay now expect to
live into their thirties or forties [2]. Of these interventions
antibiotic therapy has probably made the most significant
contribution to improved survival rates by suppressing the
frequent respiratory exacerbations experienced by sufferers.
Specific micro-organisms, principally Staphylococcus aureus,
Haemophilus influenzae, Pseudomonas aeruginosa and Burkhol-⁎ Corresponding author. Tel.: +44 141 201 0422; fax: +44 141 201 0413.
E-mail address: craig.williams@ggc.scot.nhs.uk (C. Williams).
1569-1993/$ - see front matter © 2010 European Cystic Fibrosis Society. Publishe
doi:10.1016/j.jcf.2010.09.001deria cepacia, are associated with infection in CF, but of these
P. aeruginosa has the greatest clinical impact. This organism is
ubiquitous in nature and poses little threat to healthy individuals
but in the CF lung can induce an exaggerated inflammatory
response which contributes significantly to tissue damage and
decline in both respiratory function and clinical condition [3].
The situation has been described as a “vicious cycle” in which
infection induces inflammation and tissue damage which
predisposes to further infection [4].
In CF, acquisition of P. aeruginosa can occur early in life.
The development of chronic lung infections follows a
characteristic pattern, that is a period of intermittent colonisa-
tion with P. aeruginosa early in the life of the patient [5,6] with
early infecting strains typically resembling those found in the
environment, that is nonmucoid, fast growing, and relatively
susceptible to antibiotics [7]. This stage is temporary, and
eventually the airways of nearly all patients become perma-
nently colonised with a mucoid P. aeruginosa.
After initial colonisation, a window of opportunity exists,
during which establishment of chronic infection may be delayedd by Elsevier B.V. All rights reserved.
Table 1
Results of cough swab specimens tested for P. aeruginosa.
Culture PCR
+ −
+ 26 0
− 28 446
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To improve overall outcome therefore particular emphasis
needs to be placed on the early detection of P. aeruginosa in
respiratory secretions and initiation of early antibiotic therapy in
an attempt to eradicate the bacterium. Should this opportunity
be missed, a state of chronic carriage will ensue in which strains
of P. aeruginosa adapt to the environment of the CF lung,
display a mucoid phenotype and form complex biofilms [10]
which are resistant to multiple antibiotics.
The aim of this investigation was to determine whether a
qPCR method would be more sensitive than conventional
microbial culture for the detection of P. aeruginosa in the
respiratory tract of young CF sufferers.
2. Methods
All specimens were collected during an 8 month period
between May 2007 and December 2008 from paediatric cystic
fibrosis patients between the ages of 0 and 15 years from the
West of Scotland attending the Royal Hospital for Sick
Children, Glasgow. Patients attended routine clinics on average
every 1 to 2 months. Consistent with routine clinical care,
cough swabs and sputum samples were obtained by phy-
siotherapists. Forty-two sputum samples were collected from 25
patients. Thirty-nine percent of these patients were female, 61%
male. Twenty-two percent were in the 5 to 9 year group and
78% in the 10 to 15 year group. Swabs were collected on 500
occasions from 161 patients unable to produce sputum for
collection. Fifty-one percent of these patients were female, 49%
male. Thirty-five percent were in the 0 to 4 year group, 29% in
the 5 to 9 year group and 36% in the 10 to 15 year group.
Routine bacteriological culture was performed along with
qPCR specific for P. aeruginosa.
Culture was performed by inoculating the specimen onto the
following media: blood, chocolate bacitracin, MacConkey and
Sabouraud agar for general microbial culture and P. aeruginosa
and B. cepacia selective agars to enhance detection of these
specific pathogens. The selective plates were incubated for 48 h
at 37 °C aerobically before suspect colonies were purified and
identified phenotypically.
DNA was extracted from swabs and sputa using the EZ1
extraction robot (QIAGEN) and a tissue extraction kit. Swabs
were washed in 1 ml of sterile phosphate buffered saline and
150 μl of the solution was mixed with the extraction buffer and
proteinase K (as supplied with the kit). The extraction buffer
and proteinase K was added directly to 150 μl of each sputum
sample. All samples were incubated at 56 °C for 15 min
followed by standard extraction as per manufacturer's instruc-
tions. DNA was eluted in 100 μl.
The specificity of the qPCR reaction was tested by
examining bacteria commonly found in normal respiratory
flora, organisms associated with CF respiratory specimens and
strains genotypically related to P. aeruginosa. DNA was
extracted from these organisms by re-suspending 1 or 2
colonies in 200 μl extraction buffer and using the standard
extraction protocol. DNA was eluted in 200 μl. Extracted DNA
was tested using qPCR with P. aeruginosa specific primers(Pa23F-TCC AAG TTT AAG GTG GTA GGC TG and Pa23R-
ACC ACT TCG TCA TCT AAA AGA CGA C) and Taqman
probe (Pa23P-6-FAM-AGG TAA ATC CGG GGT TTC AAG
GCC-TAMRA) as previously described [11]. The qPCR
program consisted of 50 °C for 2 min, 95 °C for 15 min and
40 cycles of 95 °C for 15 s and 60 °C for 1 min with a plate read
after every cycle. Fluorescence was detected and captured using
an ABI 7000 detection system. Automated analysis using ABI
Prism software calculated the Ct values. PCR positivity was
defined as a Ct value of b40. A standard curve of known con-
centrations ofP. aeruginosa bacteria determined the sensitivity of
the assay to be 85 cfu/ml.
Positive qPCR reactions were prepared for sequencing by
cleaning using shrimp alkaline phosphatase and sequenced to
determine the specificity of the reaction using ABI 3100 and a
standard BigDye protocol.
Due to the ubiquitous nature of P. aeruginosa a number of
negative controls were incorporated into the process. With each
batch of samples a sample of nuclease free water was processed
to insure no contamination in the extraction protocol. Also prior
to the start of the study 3 swabs from 3 different lot numbers
were also tested to ensure negativity.3. Results
Of the cough swabs analysed culture and qPCR were
positive in 26 samples whereas qPCR was positive alone in an
additional 28 (Table 1), an increase in detection of over 100%.
This increase would have resulted in a further 25 patients being
diagnosed with P. aeruginosa 13 of these patients had no
previous history of P. aeruginosa and 5 had no P. aeruginosa
positive samples in the previous 2 years. The 7 remaining
qPCR positive only cough swabs were from patients who had
been either intermittently or chronically colonised with
P. aeruginosa. For cough swabs this gives a sensitivity and
specificity of 100% and 52% respectively. The results of cough
swab analyses are shown in Table 1.
When sputumwas examined 22 sampleswere positive for both
culture and qPCR and a further 10 were positive only by qPCR
(Table 2) a 45% increase in positivity which equated to an
additional 8 patients being diagnosed as positive 4 of which had
noP. aeruginosa positive samples in the previous 18 months. For
the 4 remaining qPCR positive only sputa were from patients who
had been either intermittently or chronically colonised with
P. aeruginosa. For sputum samples this gives a sensitivity and
specificity of 100% and 31% respectively. The results of sputum
analyses are shown in Table 2.
Table 2
Results of sputum specimens tested for P. aeruginosa.
Culture PCR
+ −
+ 22 0
− 10 10
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conventional culture was positive.
In total 38 qPCR positive culture negative specimens were
obtained from 31 different patients. Further analysis of thesePatient
1 07.06.07 CS
2 27.06.07 CS 05.09.07 CS
3 04.09.07 CS 19.09.07 CS
4 23.05.07 CS 27.08.07 CS 31.10.07 CS
5 18.07.07 CS 12.09.07 CS 12.11.07 CS
6 19.09.07 CS 20.11.07 CS 05.12.07 CS
7 04.07.07 CS 29.08.07 CS 07.11.07 CS
8 30.05.07 CS 30.07.07 CS 21.11.07 CS
9 23.07.07 CS 12.09.07 CS 19.11.07 CS
10 18.07.07 CS 12.09.07 CS 19.11.07 CS
11 21.05.07 CS 16.10.07 CS 07.05.08 CS
12 27.06.07 CS 10.07.07 CS 05.09.07 CS 21.
13 04.07.07 CS 28.08.07 CS 03.10.07 CS 05.
14 27.06.07 CS 08.08.07 CS 24.10.07 SPT 19.
15 19.06.07 CS 25.07.07 CS 08.08.07 CS 12.
16 09.07.07 CS 05.09.07 CS 23.10.07 CS 15.
17 23.05.07 CS 30.05.07 CS 25.07.07 CS 19.
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29 06.06.07 CS 20.06.07 CS 29.08.07 CS 07.
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31 06.08.07 CS 21.09.07 SPT 08.10.07 CS 12.
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33 24.05.07 CS 17.07.07 CS 23.07.07 CS 01.
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Fig. 1. Results from all samples collected from patientspecimens revealed that 24 were sporadic single sample
positives and the remaining 14 were patients who had
either multiple PCR positive samples or a mix of culture and
PCR only positive samples. These results are summarised in
Fig. 1.
The specificity of the qPCR method was confirmed by
sequencing of the qPCR products from positive specimens to
ensure that the sequence matched the P. aeruginosa target
sequence by BLAST search of the NCBI database. All positive
results matched with ≥98% homology. The qPCR signal was
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Since young children are generally unable to produce
sputum, detection of bacterial colonisation in young CF suf-
ferers relies on cough swabs. However these samples poorly
reflect the presence of organisms deeper in the respiratory tract
and a negative cough swab does not rule out infection [12]. The
use of qPCR on cough swabs as well as sputa allowed a
significant improvement in the detection of P. aeruginosa over
routine bacteriological culture. Given the ability of early
antimicrobial therapy to eradicate carriage, this method has
the potential to delay clinical deterioration in CF sufferers.
A previous study using a multiplex PCR on respiratory
samples showed P. aeruginosawas isolated by culture in 56% of
samples while PCRwas positive in 78.7% giving a sensitivity and
specificity of multiplex PCR for bacterial identification, com-
pared to culture, of 97.2% and 45.5% respectively [13].
A further study using a combination of PCR and Serology
showed that it was possible to isolate P. aeruginosa by culture
in samples from 42 patients (48.2%), while PCR was positive in
53 (60.9%) [14]. Our results show that in cough swabs
P. aeruginosa was positive by culture in 5% samples (11%
patients) , while PCR was positive in 11% samples (16%
patients) and in sputa P. aeruginosa was positive by culture in
52% of samples (44% patients), while PCR was positive in 76%
samples (76% patients).
While this molecular test clearly allows more sensitive
detection of P. aeruginosa than culture the implications of this
more sensitive assay require careful consideration.
Our results show that although this assay appears more
sensitive than culture, in 76% of the PCR positive only
specimens these positives, although true positives confirmed
through sequence analysis, are sporadic with prior and
subsequent specimens being negative. This may indicate the
need for more frequent screening of this patient group to ensure
that treatment is correctly directed.
The key clinical question is do most of the initial colonising,
presumably environmental strains have the ability to mutate into
strains able to cause chronic colonisation or is this ability
present in only a few strains. Prior to recent improvements in
patient segregation and cross infection control it is possible that
the sporadic acquisition of strains has been masked by high
levels of cross infection with “outbreak strains” and further
work is required to fully elucidate the epidemiology of
P. aeruginosa in the era of effective segregation.
To develop the utility of PCR diagnostics a number of further
steps are required. Firstly, the genetic relatedness between
strains detected by PCR and those which go on to establish
colonisation remains to be ascertained. Secondly, infection
control strategies are currently based on segregation of
colonised and non-colonised patients but the risk of transmis-
sion of P. aeruginosa from PCR positive/culture negative
patients will need to be assessed.
Although principally aimed at improving patient care, a
further practical advantage has emerged from this work in that
organisms such as Achromobacter xylosoxidans, Pandoraea
spp., Pseudomonas putida, Pseudomonas fluorescens, Ralstoniamannitolytica, Ralstonia pickettii and Burkholderia glagioli that
are phenotypically and biochemically similar to P. aeruginosa
produced negative PCR results. These organisms may be difficult
to fully identify in a routine diagnostic laboratory and unnecessary
infection control restrictions may have to remain in place while
Reference Laboratory tests are performed. The rapid turn-around
time of the PCR method allows the presence of P. aeruginosa to
be ruled out, even prior to conventional culture results becoming
available.
In conclusion the use of qPCR significantly increases the
detection rate of P. aeruginosa from cough swabs collected
from paediatric CF sufferers. Further work is required to
elucidate whether strains detected by this method go on to
establish colonisation. This would require a further longitudinal
study. The adequacy of current infection control measures
requires to be reassessed in the light of this more sensitive
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